Galmed Pharmaceuticals Ltd. Shares Close the Day 14.6% Higher - Daily Wrap

The company saw its shares close the day 14.6% higher than yesterday, with trading volume higher than its 30 day average.

Mar 19, 2021 by Kwhen Finance Editors

Galmed Pharmaceuticals Ltd. Shares Close the Day 14.6% Higher - Daily Wrap
Galmed Pharmaceuticals Ltd. shares closed today 14.6% higher than it did at the end of yesterday. The stock is currently up 26.0% year-to-date, up 9.5% over the past 12 months, and down 17.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.8%, and the S&P 500 fell 0.2%.

Trading Activity

  • Shares traded as high as $3.95 and as low as $3.42 this week.
  • Shares closed 4e+1% below its 52-week high and 3e+1% above its 52-week low.
  • Trading volume this week was 35.5% lower than the 10-day average and 16.5% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Galmed Pharmaceuticals Ltd.14.626.09.5
Dow Jones Industrial Average-0.87.173.3-1.283.8
S&P 500 Index-0.24.573.0-1.781.5
Health Care0.51.551.4-4.061.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 111.0%
  • The company's stock price performance over the past 12 months lags the peer average by -93.2%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Galmed Pharmaceuticals Ltd.GLMD026.09.5
Peer AvgN/A16.712.3140.4-4.744.9
Catalent IncCTLT61.81.9170.4-18.7179.5
Endo International PlcENDP10.213.8171.4
Aerie Pharmaceuticals Inc.AERI-5.045.766.3
Evoke Pharma Inc.EVOK0-12.0153.4

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: